Menzella F - Search Results

1

Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation.

Bagnasco D, Menzella F, Caminati M, Caruso C, Guida G, Bonavia M, Riccio A, Milanese M, Manfredi A, Senna G, Passalacqua G. Bagnasco D, et al. Among authors: menzella f. Allergy. 2019 Dec;74(12):2539-2541. doi: 10.1111/all.13937. Epub 2019 Jul 1. Allergy. 2019. PMID: 31166605 No abstract available.

2

Baseline Characteristics of Patients Enrolled in Clinical Trials of Biologics for Severe Asthma as Potential Predictors of Outcomes.

Menzella F. Menzella F. J Clin Med. 2023 Feb 15;12(4):1546. doi: 10.3390/jcm12041546. J Clin Med. 2023. PMID: 36836079 Free PMC article. Review.

3

Omalizumab: when the non-responder is a late-responder.

Menzella F, Facciolongo N, Castagnetti C, Simonazzi A, Zucchi L. Menzella F, et al. Eur Ann Allergy Clin Immunol. 2009 Oct;41(5):155-9. Eur Ann Allergy Clin Immunol. 2009. PMID: 20101930

4

A survey of clinical features of allergic rhinitis in adults.

Frati F, Dell'Albani I, Passalacqua G, Bonini S, Rossi O, Senna G, Incorvaia C; Adult SURF Study Group. Frati F, et al. Med Sci Monit. 2014 Nov 4;20:2151-6. doi: 10.12659/MSM.891206. Med Sci Monit. 2014. PMID: 25366169 Free PMC article.

5

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases.

Menzella F, Lusuardi M, Galeone C, Taddei S, Zucchi L. Menzella F, et al. J Asthma Allergy. 2015 Oct 8;8:105-14. doi: 10.2147/JAA.S40244. eCollection 2015. J Asthma Allergy. 2015. PMID: 26504401 Free PMC article. Review.

6

Real-life Efficacy of Omalizumab After 9 Years of Follow-up.

Menzella F, Galeone C, Formisano D, Castagnetti C, Ruggiero P, Simonazzi A, Zucchi L. Menzella F, et al. Allergy Asthma Immunol Res. 2017 Jul;9(4):368-372. doi: 10.4168/aair.2017.9.4.368. Allergy Asthma Immunol Res. 2017. PMID: 28497924 Free PMC article.

7

Towards precision medicine: The application of omics technologies in asthma management.

Scelfo C, Galeone C, Bertolini F, Caminati M, Ruggiero P, Facciolongo N, Menzella F. Scelfo C, et al. Among authors: menzella f. F1000Res. 2018 Apr 4;7:423. doi: 10.12688/f1000research.14309.2. eCollection 2018. F1000Res. 2018. PMID: 29904594 Free PMC article.

8

Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for "Omics" Technology?

Galeone C, Scelfo C, Bertolini F, Caminati M, Ruggiero P, Facciolongo N, Menzella F. Galeone C, et al. Among authors: menzella f. Biomed Res Int. 2018 Jun 11;2018:4617565. doi: 10.1155/2018/4617565. eCollection 2018. Biomed Res Int. 2018. PMID: 29992143 Free PMC article. Review.

9

The Severe Asthma Network in Italy: Findings and Perspectives.

Heffler E, Blasi F, Latorre M, Menzella F, Paggiaro P, Pelaia G, Senna G, Canonica GW; SANI Network. Heffler E, et al. Among authors: menzella f. J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1462-1468. doi: 10.1016/j.jaip.2018.10.016. Epub 2018 Oct 25. J Allergy Clin Immunol Pract. 2019. PMID: 30368004 Free article.

10

Severe refractory asthma: current treatment options and ongoing research.

Menzella F, Bertolini F, Biava M, Galeone C, Scelfo C, Caminati M. Menzella F, et al. Drugs Context. 2018 Dec 5;7:212561. doi: 10.7573/dic.212561. eCollection 2018. Drugs Context. 2018. PMID: 30534175 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters